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A  50-year  old  female  with  no  remarkable  medical  history  consulted  her  doctor  because
of  persistent  epigastric  pain.  The  clinical  examination  was  unremarkable  and  laboratory
tests  were  normal.
Ultrasonography  revealed  a  subumbilical,  homogeneous,  echogenic  mass  with  an  axial
diameter  of  5  cm.  The  mass  had  regular  margins,  posterior  acoustic  enhancement,  and  no
visible  vascularisation  on  colour  Doppler  imaging.
Computed  tomography  (CT)  of  the  abdomen  and  pelvis  before  and  after  administration
of  iodinated  contrast  material  showed  a  tissue  mass  located  in  the  mesentery  with  reg-
ular  margins,  no  calciﬁcation,  no  communication  with  the  bowel  loops,  and  attenuation
values  of  70  HU  before  injection.  After  intravenous  administration  of  iodinated  contrast
material,  CT  demonstrated  discontinuous,  peripheral  nodes  that  enhanced  centripetally,
with  a  dynamic  pattern  of  enhancement  identical  to  that  of  the  aorta  and  which  persisted
during  the  delayed  phase.  Multiple  vessels  were  visible  within  the  mass  including  a  branch
of  the  superior  mesenteric  artery,  but  there  was  no  thrombosis  or  obstruction  (Fig.  1).  No
enlarged  lymph  node  was  visible.
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Figure 1. Asymptomatic mesenteric hemangioma in a 50-year-old
woman. CT image of the mid abdomen in the sagittal plane during
the enteric phase of enhancement shows a well-circumscribed mass
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Figure 3. Mesenteric cavernous hemangioma. a: fat-
suppressedT1-weighted gradient-echo (TR/TE = 3.67/1.85 ms,
ﬂip angle = 10◦) MR image in the axial plane during the enteric
phase shows progressive enhancement with peripheral nodular
enhancement (arrow); b: fat-suppressed T1-weightedgradient-echo
(TR/TE = 3.67/1.85 ms, ﬂip angle 10◦) MR image in the axial plane
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Surgical  resection  was  thus  decided.  Intraoperatively,  a
mesenteric  mass  with  no  extension  to  the  bowel  loops  wasf the mesentery (white arrow), with peripheral nodular enhance-
ent that has narrow channels of communication with the superior
esenteric artery (black arrow) and vein (arrowhead).
MR  imaging  showed  high  signal  intensity  lesion  on  T2-
eighted  sequences  (Fig.  2)  and  low  signal  intensity  on
iffusion-weighted  MR  images  (B50  and  B1000)  with  no
rop  in  apparent  diffusion  coefﬁcient  value  (ADC  =  1.9  *
0—3  mm2/sec)  on  diffusion-weighted  images.  The  oval
ass  also  showed  regular  margins  and  contained  threadlike
ormations,  which  were  suggestive  of  vascular  structures
xtending  from  the  mesenteric  vessels.
On  unenhanced  T1-weighted  images,  the  lesion  was
omogenous  with  intermediate  signal  intensity.  After
ntravenous  administration  of  gadolinium-chelate,  the
nhancement  pattern  was  similar  to  that  seen  on  CT  (Fig.  3).
igure 2. T2-weighted (TR/TE = 850/102 ms, ﬂip angle = 180◦) MR
mage in the axial plane demonstrates a lesion with a higher signal
ntensity than fat, similar to that of a hepatic hemangioma (arrow).
F
turing the delayed phase shows persistent enhancement with
entripetal ﬁll-in, greater than during the enteric phase (arrow).
Percutaneous  biopsy  was  not  considered  in  view  of  the
ascularisation  of  the  lesion,  difﬁculty  of  access,  and  its
elationships  to  the  large  mesenteric  vessels.igure 4. Laparoscopic view. The lesion is located in the mesen-
ery without extension to the gastrointestinal tract wall.
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found  (Fig.  4).  The  mass  was  resected  along  with  20  cm  of
the  jejunum.
Histopathological  examination  of  the  resected  speci-
men  revealed  a  well-marginated  vascular  lesion.  The  lesion
was  made  of  multiple  dilated  cavities  lined  with  ﬂattened
endothelium  with  no  nuclear  atypia  that  were  separated
by  septa  of  ﬁbrous  connective  tissue.  The  vessel  lumen
showed  thrombosis  and  contained  numerous  red  blood
cells  (Fig.  5).  Immunolabelling  for  CD31,  which  is  vascu-
lar  endothelium-speciﬁc,  was  positive  in  the  cytoplasm.
It  was  however  negative  for  the  lymphatic  endothelial
marker  D2-40.  Smooth  muscle  actin  marked  the  smooth
muscle  component  of  the  vessel  walls.  The  lesion  was
deﬁnitely  diagnosed  as  a  cavernous  hemangioma  of  the
mesentery.  Follow-up  at  1  year  showed  no  recurrence  of  the
lesion.
Figure 5. Photograph shows histopathological features (HE stain,
original magniﬁcation ×20) of the lesion that contains large cavities
ﬁlled with red blood cells and bordered by endothelium resting on
an abundant ﬁbrous stroma.
Discussion
The  lesion  reported  showed  clinical,  radiological  and  histo-
logical  features  similar  to  those  of  cavernous  hemangiomas
found  in  the  abdomen  including  hepatic  hemangioma  [1,2].
Like  these,  it  was  clinically  asymptomatic  with  no  internal
hemorrhage  or  infection  and  no  mass  effect  on  adjacent
organs.
On  ultrasonography,  the  lesion  was  hyperechoic  with
posterior  acoustic  enhancement.  On  CT,  it  demonstrated
tissue  density  and  enhancement  pattern  characteristic  of
angiomas.  MR  imaging  showed  no  restriction  on  diffusion-
weighted  images  and  typical  high  signal  intensity  on
T2-weighted  images  similar  to  typical  pattern  of  heman-
giomas.  Unusually,  a  rich  vascular  component  made  up  of
superior  mesenteric  vessels  is  present  making  it  necessary
to  excise  a  portion  of  the  superior  mesenteric  artery  during
surgery.
Histologically,  the  lesion  showed  multiple  dilated  cavi-
ties  with  vessel  lumina  that  showed  thrombosis  in  places
and  contained  red  blood  cells.  CD31  immunolabelling,  a
speciﬁc  marker  for  vascular  endothelium,  was  positive
[3,4].
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A  review  of  the  literature  found  a  few  cases  of  mesen-
eric  cavernous  hemangioma  [5,6]. They  do  not  have  any
haracteristic  imaging  or  histological  features.  By  contrast,
ultiple  cases  of  cavernous  hemangioma  were  found  in  the
iver  [1,2], and  more  rarely  in  unusual  locations  including
astrosplenic  ligament  [7],  small  bowel  [8], colon,  and  rec-
osigmoid  junction  [9].
A percutaneous  biopsy  was  considered  in  our  patient
ecause  it  is  often  recommended  in  hepatic  angioma  with
typical  presentation  [10]. However,  percutaneous  biopsy
as  disregarded  because  of  a  deep  location  and  high  risk
f  iatrogenic  complication.  Surgical  excision  was  thus  cho-
en,  taking  into  account  the  possibility  of  complications  such
s  hemorrhage  or  secondary  infection.  According  to  Freeny
t  al.,  the  rate  of  complications  linked  to  size  in  hepatic
emangiomas  is  between  4.5%  and  19.7%.  There  are  two
ypes  of  complications:  on  the  one  hand,  complications  that
re  speciﬁc  to  the  lesion  such  as  thrombosis  or  inﬂammation;
nd  on  the  other,  more  general  and  systemic  complications
uch  as  hemorrhage,  volvulus,  or  compression  of  adjacent
rgans  [1,11].
On  imaging,  if  a  mesenteric  mass  is  identiﬁed,  this
ust  lead  to  a  consideration  of  the  differential  diagnoses,
istinguishing  the  ﬂuid  lesions,  consisting  of  cystic  lymphan-
ioma  and  mesothelial  lesions,  from  solid  masses  including
esmoid  tumour,  solitary  ﬁbrous  tumour,  peritoneal  carci-
osis,  and  leiomymomatosis,  and  also  from  fat-containing
esions  such  as  teratoma  and  lipoma  [12,13].  In  our  patient,
he  lesion  was  purely  solid  with  no  cystic  or  fatty  compo-
ent.  This  was  conﬁrmed  by  imaging,  with  ultrasonography
howing  a hyperechoic  echostructure,  CT  demonstrating  a
esion  with  soft  tissue  attenuation  values,  and  MRI  show-
ng  an  intermediate  signal  intensity  on  T1-weighted  images
ith  centripetal  enhancement  after  injection  of  a contrast
edium  and  no  drop  in  signal  intensity  on  out-of-phase  T1-
eighted  sequences.
When  considering  only  solid  tumours,  three  groups  can
e  distinguished  on  the  basis  of  enhancement  patterns.
redominant  enhancement  during  the  arterial  phase  sug-
ests  gastrointestinal  stromal  tumour,  Castleman’s  disease,
olitary  ﬁbrous  tumour,  and  splenosis  nodule.  Predominant
nhancement  during  the  enteric  phase,  suggests  desmoid
umour,  actinomycosis,  carcinomatosis  nodule  or  solitary
brous  tumor.  Finally,  poor  enhancement  on  both  suggests
ymphoma,  inﬂammatory  pseudotumour  or  endometriosis.
In  our  patient,  the  lesion  showed  predominant  enhance-
ent  during  the  arterial  phase.  However,  gastrointestinal
tromal  tumor  is  hypervascular  and  well  demarcated,  com-
unicates  with  the  bowel  loop  and  shows  extraluminal
rowth.  The  angioma-type  pattern  of  enhancement  and  the
igh  signal  intensity  on  T2-weighted  images  were  not  consis-
ent  with  Castleman’s  disease.  Our  patient  had  no  history  of
rauma,  surgery,  infection  or  splenic  tumor  and  the  enhance-
ent  pattern  was  not  identical  to  that  of  the  spleen.  In
ddition,  these  nodules  are  found  around  the  gastrosplenic
r  splenorenal  ligaments  or  the  space  around  the  diaphragm
o  that  the  diagnosis  of  splenosis  nodule  was  excluded.  Soli-
ary  ﬁbrous  tumor  is  usually  asymptomatic,  until  it  leads
o  a  mass  effect.  In  addition,  it  is  hypervascular  with  a
ecrotic  center  and  tends  to  present  small  peripheral  ves-
els  rather  than  large-  and  medium-calibre  vessels  like  in
ur  patient.
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onclusion
he  diagnosis  of  mesenteric  hemangioma  should  be  consid-
red  in  the  presence  of  a  mesenteric  tumor  that  presents
linical,  imaging  and  pathological  features  that  are  identical
o  those  of  hepatic  hemangioma.  The  diagnosis  is  deﬁnitely
onﬁrmed  by  histopathological  analysis.
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